Opioid Reduction Following Spinal Cord Stimulation
WithdrawnNot applicableNCT02727985
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
The primary purpose of this study is to compare opioid use post-spinal cord stimulation implant at 1, 3, 6, 9 and 12 month intervals in patients who were provided with a weaning schedule by the Neuromodulation team (experimental group) versus those who wean on their own or with their family doctor (control group; standard care) to determine if one strategy is superior to the other. The secondary objectives will be to further characterize change in opioid use as it relates to pain scores, quality of life and disability from baseline to follow-up assessments. The investigators will examine changes in opioid-related adverse events and medication costs to help understand the impact of opioid weaning on the patient and the system. The investigators will also compare worker's compensation patients with non-worker compensation patients to see if they follow the same result pattern.
Study details
- Official title
- Opioid Reduction Following Spinal Cord Stimulation: A Comparison of Two Protocols, Effect on Patient Quality of Life and Cost-Impact to the Healthcare System
- Conditions
- Interventions
- Procedure: Pharmacist weaning schedule
- Sponsor
- Saskatchewan Health Authority - Regina Area
- Start date
- 2016-03
- Primary completion
- 2018-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Subject must be taking at least 1 opioid for a minimum of 6 months * Subject is a candidate for spinal cord stimulation procedure Exclusion Criteria: * Palliative * Documented substance abuse * Subject less than 18 years of age * Subject is unwilling or unable to attend required visits and/or comply with study requirements * Subjects are unable to undergo study assessments or complete questionnaires independently i.e.: illiterate * Subject has enrolled or plans to enroll in any study that might confound the study results
Canadian sites (1)
| Facility | City | Province |
|---|---|---|
| Regina General Hospital | Regina | Saskatchewan |
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02727985